This is a 52 kDa extracellular matrix protein which is expressed by endothelial tissues during embryonic vascular development [10] Its role in cancer and in drug resistance is not widely studied, however a few studies indicate that Edil-3 overexpression relates to poor prognosis in hepatocellular carcinoma [11]. Here, EDIL3 is linked to cancer.